256 related articles for article (PubMed ID: 26121440)
21. Desiccated thyroid extract compared with levothyroxine in the treatment of hypothyroidism: a randomized, double-blind, crossover study.
Hoang TD; Olsen CH; Mai VQ; Clyde PW; Shakir MK
J Clin Endocrinol Metab; 2013 May; 98(5):1982-90. PubMed ID: 23539727
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of L-Triiodothyronine in Patients Undergoing Thyroid Hormone Therapy Withdrawal.
Van Tassell B; Wohlford GF; Linderman JD; Smith S; Yavuz S; Pucino F; Celi FS
Thyroid; 2019 Oct; 29(10):1371-1379. PubMed ID: 31364488
[No Abstract] [Full Text] [Related]
23. Current evidence for the treatment of hypothyroidism with levothyroxine/levotriiodothyronine combination therapy versus levothyroxine monotherapy.
Hennessey JV; Espaillat R
Int J Clin Pract; 2018 Feb; 72(2):. PubMed ID: 29381251
[TBL] [Abstract][Full Text] [Related]
24. Use of levothyroxine in the management of hypothyroidism: A historical perspective.
Kahaly GJ; Gottwald-Hostalek U
Front Endocrinol (Lausanne); 2022; 13():1054983. PubMed ID: 36407302
[TBL] [Abstract][Full Text] [Related]
25. Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document.
Jonklaas J; Bianco AC; Cappola AR; Celi FS; Fliers E; Heuer H; McAninch EA; Moeller LC; Nygaard B; Sawka AM; Watt T; Dayan CM
Thyroid; 2021 Feb; 31(2):156-182. PubMed ID: 33276704
[No Abstract] [Full Text] [Related]
26. An Online Survey of Hypothyroid Patients Demonstrates Prominent Dissatisfaction.
Peterson SJ; Cappola AR; Castro MR; Dayan CM; Farwell AP; Hennessey JV; Kopp PA; Ross DS; Samuels MH; Sawka AM; Taylor PN; Jonklaas J; Bianco AC
Thyroid; 2018 Jun; 28(6):707-721. PubMed ID: 29620972
[TBL] [Abstract][Full Text] [Related]
27. The Swinging Pendulum in Treatment for Hypothyroidism: From (and Toward?) Combination Therapy.
McAninch EA; Bianco AC
Front Endocrinol (Lausanne); 2019; 10():446. PubMed ID: 31354624
[TBL] [Abstract][Full Text] [Related]
28. [Treatment of neonatal hypothyroidism. Comparative effects of levothyroxine and thyroid extracts].
Tenenbaum D; Munsch T; Juif MH; Dauvergne M; Touzery C; Pelletier JL; Nivelon JL; Pierson M
Arch Fr Pediatr; 1986 Oct; 43(8):607-9. PubMed ID: 3813782
[TBL] [Abstract][Full Text] [Related]
29. Polymorphisms in the brain-specific thyroid hormone transporter OATP1C1 are associated with fatigue and depression in hypothyroid patients.
van der Deure WM; Appelhof BC; Peeters RP; Wiersinga WM; Wekking EM; Huyser J; Schene AH; Tijssen JG; Hoogendijk WJ; Visser TJ; Fliers E
Clin Endocrinol (Oxf); 2008 Nov; 69(5):804-11. PubMed ID: 18410547
[TBL] [Abstract][Full Text] [Related]
30. MANAGEMENT OF ENDOCRINE DISEASE: Pitfalls on the replacement therapy for primary and central hypothyroidism in adults.
de Carvalho GA; Paz-Filho G; Mesa Junior C; Graf H
Eur J Endocrinol; 2018 Jun; 178(6):R231-R244. PubMed ID: 29490937
[TBL] [Abstract][Full Text] [Related]
31. A Cross-Sectional Analysis of Cardiovascular and Bone Health Care Utilization During Treatment With Thyroid Hormone.
Penna GC; Bianco AC; Ettleson MD
J Clin Endocrinol Metab; 2024 Feb; 109(3):e1143-e1150. PubMed ID: 37878964
[TBL] [Abstract][Full Text] [Related]
32. A Systematic Review of Clinical Practice Guidelines' Recommendations on Levothyroxine Therapy Alone versus Combination Therapy (LT4 plus LT3) for Hypothyroidism.
Kraut E; Farahani P
Clin Invest Med; 2015 Dec; 38(6):E305-13. PubMed ID: 26654514
[TBL] [Abstract][Full Text] [Related]
33. Recent evidence sets therapeutic targets for levothyroxine-treated patients with primary hypothyroidism based on risk of death.
Perros P; Nirantharakumar K; Hegedüs L
Eur J Endocrinol; 2021 Feb; 184(2):C1-C3. PubMed ID: 33306038
[TBL] [Abstract][Full Text] [Related]
34. Predicting Optimal Combination LT4 + LT3 Therapy for Hypothyroidism Based on Residual Thyroid Function.
DiStefano J; Jonklaas J
Front Endocrinol (Lausanne); 2019; 10():746. PubMed ID: 31803137
[No Abstract] [Full Text] [Related]
35. Designing a combined liothyronine (LT3), L- thyroxine (LT4) trial in symptomatic hypothyroid subjects on LT4 - the importance of patient selection, choice of LT3 and trial design.
Premawardhana LD; Taylor PN; Okosieme OE; Adlan MA; Obuobie EK; Dayan CM
Front Endocrinol (Lausanne); 2023; 14():1282608. PubMed ID: 38034018
[TBL] [Abstract][Full Text] [Related]
36. Design of the Optimal Trial of Combination Therapy.
Cappola AR
Front Endocrinol (Lausanne); 2020; 11():168. PubMed ID: 32318021
[TBL] [Abstract][Full Text] [Related]
37. Prescribing Therapy for Hypothyroidism: Influence of Physician Characteristics.
Jonklaas J; Tefera E; Shara N
Thyroid; 2019 Jan; 29(1):44-52. PubMed ID: 30375273
[TBL] [Abstract][Full Text] [Related]
38. Thyroid hormone therapy in congenital hypothyroidism and pediatric hypothyroidism.
Bauer AJ; Wassner AJ
Endocrine; 2019 Oct; 66(1):51-62. PubMed ID: 31350727
[TBL] [Abstract][Full Text] [Related]
39. Heart Failure and Stroke Risks in Users of Liothyronine With or Without Levothyroxine Compared with Levothyroxine Alone: A Propensity Score-Matched Analysis.
Yi W; Kim BH; Kim M; Kim J; Im M; Ryang S; Kim EH; Jeon YK; Kim SS; Kim IJ
Thyroid; 2022 Jul; 32(7):764-771. PubMed ID: 35570696
[No Abstract] [Full Text] [Related]
40. LT4 and Slow Release T3 Combination: Optimum Therapy for Hypothyroidism?
Azizi F; Amouzegar A; Mehran L; Abdi H
Int J Endocrinol Metab; 2020 Apr; 18(2):e100870. PubMed ID: 32636887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
